Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Pancreatic Cancer - Report summarizes pancreatic cancer study findings from University of California
Pancreatic Cancer - Research from Kyung-Hee University provide new insights into pancreatic cancer
Prostate Cancer - New prostate cancer data have been reported by scientists at University of London, Imperial College
Sickle Cell Anemia - Research from National Heart, Lung, & Blood Institute has provided new information about sickle cell anemia
Solid Cancer - Research on solid cancer discussed by scientists at University of Texas
Ulcerative Colitis - Studies from C. Penarossi and co-researchers in the area of ulcerative colitis published
Vomiting - Data from Indiana University advance knowledge in vomiting
Acne Vulgaris Therapy - Reports summarize acne vulgaris therapy research from J.J. Leyden and co-authors
Apoptosis Cell Biology - Reports outline apoptosis cell biology research from Shanghai Institute of Materia Medica, Research Division
Gastric Cancer Therapy - New gastric cancer therapy research from Chonnam National University, National University Medical School outlined
Neuroticism - Studies from L. Almeida and co-researchers update current data on neuroticism
Pharmacodynamics - Studies from A. Sutton and colleagues reveal new findings on pharmacodynamics
Acorda Therapeutics, Inc. - Acorda Therapeutics To Present Phase 3 Fampridine-SR Data at World Congress on Treatment and Research in Multiple Sclerosis Meeting
Adverse Drug Reactions - Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
Alzheimer Disease - AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Disease
Biotechnology Business - Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
Cancer Vaccines - Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
Cerus Corporation - Cerus and German Red Cross to Collaborate on INTERCEPT Red Blood Cell System Development
Clinical Trial Research - Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
Clinical Trial Research - SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
Depomed, Inc. - Depomed Initiates Phase 3 Program in Menopausal Hot Flashes
Diabetic Neuropathy - Sangamo BioSciences Announces Presentation of Data From Diabetic Neuropathy Clinical Trials
Drug Resistance - Enanta Initiates Phase 1 Study on EDP-322, an Oral Antibiotic With Activity Against Hospital- and Community-Acquired MRSA
Enzyme Research - S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
Flu Vaccines - Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
Flu Vaccines - Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
Hollis-Eden Pharmaceuticals, Inc. - Hollis-Eden Pharmaceuticals Reports Update on Autoimmunity Program with TRIOLEX HE3286 at International Autoimmunity Meeting
Hot Flashes - Bionovo's MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
Javelin Pharmaceuticals, Inc. - Javelin Pharmaceuticals Completes Patient Enrollment for Second of two Pivotal Phase 3 Studies of Dyloject
Melanoma - Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
Merck & Co., Inc. - Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Increased Bone Mineral Density BMD Over Two Years at Key Fracture Sites in Phase IIB Study
Multiple Sclerosis - Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
NicOx - NicOx Announces Second Naproxcinod Pivotal Phase 3 Study 302 Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
NPS Pharmaceuticals - NPS Pharmaceuticals to Report GATTEX Data at ESPEN, ACG, UEGW Congresses
NPS Pharmaceuticals, Inc. - Positive Interim Data from Phase 2 Study of NPSP558 Parathyroid Hormone 1-84 for Hypoparathyroidism Reported at ASBMR Annual Meeting
Penile Induration - BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease
Pfizer - Pfizer Oncology Presents Safety and Efficacy Results of CP-751,871 Study At ESMO 2008
Pfizer Inc - MannKind and Pfizer Announce Collaboration for Certain Exubera Patients to Transition to MannKind's Inhaled Insulin Therapy
Psoriasis - Findings From Landmark Study Show Ustekinumab Demonstrated Superior Efficacy to Enbrel(R) (Etanercept) in Treatment of Moderate to Severe Plaque Psoriasis
Spinal Cord Injury - The European Commission Grants Orphan Drug Designation to Alseres Pharmaceuticals' Spinal Cord Injury Treatment, Cethrin(R)
